Ian A. Rowe

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Agree to disagree: Increasing the impact of recommendations formulated through Delphi methodology.

Agree to disagree: Increasing the impact of recommendations formulated through Delphi methodology.

Journal: Journal of hepatology

Published: May 04, 2026

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.

Journal: Journal of hepatology

Published: April 30, 2026

Incidence of Cardiovascular Events and Extrahepatic Malignancies in Steatotic Liver Disease Subgroups.

Incidence of Cardiovascular Events and Extrahepatic Malignancies in Steatotic Liver Disease Subgroups.

Journal: Digestive diseases and sciences

Published: January 24, 2026

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

Journal: The lancet. Gastroenterology & hepatology

Published: December 21, 2025

Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study.

Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study.

Journal: Radiology

Published: December 09, 2025

Optimal strategies to prevent disease progression and clinical events in MASLD.

Optimal strategies to prevent disease progression and clinical events in MASLD.

Journal: Journal of hepatology

Published: November 13, 2025

MELD 3.i and the case for continuous updating in liver allocation.

MELD 3.i and the case for continuous updating in liver allocation.

Journal: JHEP reports : innovation in hepatology

Published: October 03, 2025

Temporal trends in alcohol-related liver disease mortality and prior inpatient care in England before, during and after the COVID-19 pandemic (2004-2024): a population-based observational study.

Temporal trends in alcohol-related liver disease mortality and prior inpatient care in England before, during and after the COVID-19 pandemic (2004-2024): a population-based observational study.

Journal: Journal of epidemiology and community health

Published: September 26, 2025

Using the enhanced liver fibrosis test to identify disease in at-risk populations.

Using the enhanced liver fibrosis test to identify disease in at-risk populations.

Journal: BMJ open gastroenterology

Published: August 28, 2025

Reply: A prognostic model in patients with alcohol-associated cirrhosis does exist.

Reply: A prognostic model in patients with alcohol-associated cirrhosis does exist.

Journal: Hepatology (Baltimore, Md.)

Published: August 27, 2025

HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control study.

HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control study.

Journal: Scandinavian journal of gastroenterology

Published: June 18, 2025

Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

Predicting the Risk of Decompensation in Patients With Cirrhosis: A Validated Machine Learning Approach.

Journal: The American journal of gastroenterology

Published: June 12, 2025

Showing 1-12 of 133

Last Updated: 09/26/2026